A new study evaluating Optim-insulated implantable cardioverter defibrillator (ICD) leads found low rates of all-cause mechanical failure during a median follow-up of 3.2 years. The long-term prospective study, published in the December edition of HeartRhythm,the official journal of the Heart Rhythm Society, is the first-of-its-kind to observe a large population of patients over a relatively long follow-up period. The study assessed Durata DF4, Durata DF1 and Riata ST Optim leads to determine the rates of all-cause mechanical failure and its subtypes, including conductor fracture, insulation abrasion and externalized conductors.
Showing all archived press releases starting with 2014. Back
A new survey of more than 1,200 physicians, patients with atrial fibrillation (AFib) and their caregivers uncovered important information gaps regarding the impact of AFib-related stroke, including communication barriers, challenges with patient education, misperceptions about treatment compliance, and outcomes related to the impact of stroke on one’s life. The survey was issued by the Heart Rhythm Society (HRS) and National Stroke Association in collaboration with Boehringer Ingelheim (BI), and the findings were presented today during a special session at the American Heart Association’s annual Scientific Sessions in Chicago.
Misconceptions about atrial fibrillation (AF) are common among people nationwide, according to a new survey by the Heart Rhythm Society (HRS). More than half (56 percent) of Americans do not know that AF puts someone at a high risk of having a stroke. People are more likely to assume high risk related to other common factors like smoking, eating fried or fatty foods or drinking a lot of alcohol. HRS and the American College of Cardiology (ACC) call on Columbus residents to learn the truth about AF and encourage those who suffer from the disorder to talk to their doctors about their increased risk for stroke.
A study presented today at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions, reports significant gender and health insurance disparities in implantable cardioverter defibrillator (ICD) procedures. For the first time in nearly a decade, the new analysis of ICD implants in the United States shows a majority of implants are performed on people with insurance and more commonly in the male population.
The Heart Rhythm Society (HRS), American College of Cardiology (ACC) and American Heart Association (AHA) released Expert Consensus Statement on the Use of Implantable Cardioverter Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials today at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions. The expert consensus statement provides first-of-its-kind guidance on ICD therapy for the management of patient populations who are not well represented in clinical trials and, as a result, not specifically included in existing guidelines. View the consensus statement.
The Heart Rhythm Society released the Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated with Cardiac Sarcoidosis.
For the first time, the relationship between remote monitoring and pacemaker patient survival outcomes is revealed in a study released today at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions. The study shows that the utilization of remote monitoring can improve survival outcomes in patients with pacemakers. Furthermore, survival rates improved in patients with the highest engagement rates in remote monitoring, regardless of device type.
A first of its kind randomized trial has found that defibrillator testing (DT) at the time of implantable cardioverter defibrillator (ICD) implantation is safe, but does not improve clinical shock efficacy or prevent death. The findings are part of the Shockless Implant Evaluation (SIMPLE) trial, which was designed to answer whether or not routine DT at time of implant actually improves patient outcomes. The results were released today at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions.
Late-Breaking Clinical Trials will be revealed at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions
A new study has found that adding an electrocardiogram (ECG) to existing pre-participation screening of high school athletes increases the likelihood of identifying disorders associated with sudden cardiac death. By using modern interpretation criteria, screenings resulted in fewer false-positive rates, which leads to more accurate detection. The new findings were presented today at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions.